Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Atrial Fibrillation Drugs News Monitoring

Get by Email • RSS

Published on Mar 24, 2025

Raising Awareness of Lp(a) to Improve Heart Disease Treatment Approaches

Lipoprotein(a) (Lp[a]) levels can lead to plaque build-up in the arteries and, as such, be a notable risk marker for a myriad of cardiovascular issues. Ahead of Lp(a) Awareness on March 24, Nathan Wong, PhD, FACC, FAHA, FNLA, director, University of …

Source: The American Journal of Managed Care - Neutral
Published on Mar 24, 2025

Role and application prospective of non-steroidal MRA in the treatment of diabetic kidney disease.

Chronic kidney disease (CKD) has diverse etiologies and complex pathogenesis, and is prone to recurrent episodes and prolonged illness. In recent years, the prevalence of CKD has been increasing year by year, and the global prevalence in the general …

Source: Physician's Weekly - Neutral
Published on 01:55 GMT

Jurczak on BTK Inhibitors and the Future of B-Cell Lymphoma Therapy

Wojciech Jurczak, MD, PhD, head of the department of oncology at Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland, discusses the future of B-cell lymphoma therapy, with a focus on Bruton's tyrosine kinase (BTK) …

Source: Targeted Oncology - Label Pending
Published on 10:09 GMT

On an ancient scourge and modern interventions

Tuberculosis patients receiving treatment at the Govind Ballabh Pant Hospital in Agartala. Photograph used for representational purposes only. | Photo Credit: ANI On battling tuberculosis in India, the impact of space flight on human health, rising …

Source: The Hindu - Center-left
Published on Mar 24, 2025

Analysis of TAVI vs. SAVR in Patients With Low-Risk

Photo Credit: Ladislav The following is a summary of “Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at lower surgical risk: meta-analysis of randomized trials,” published in the March 2025 issue of the …

Source: Physician's Weekly - Neutral
Published on 09:06 GMT

Causal Relationship Between Immune Cells and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization ...

Introduction Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism, is the third most prevalent vascular disease and third leading cause of death worldwide, affecting approximately 10 million people annually.1,2 Over …

Source: Dove Medical Press - Neutral
Published on Mar 20, 2025

RWJBarnabas Health treats telenovela star

Telenovela star Clara Montero has received care for atrial fibrillation at Jersey City (N.J.) Medical Center, an affiliate of RWJBarnabas Health. Ms. Montero, known for her television, theatre and movie career, sought treatment with the center for her …

Source: Becker's ASC Review - Neutral
Published on Mar 22, 2025

The Evolution of BTK Inhibitors in B-Cell Lymphoma

Wojciech Jurczak, MD, PhD, head of the department of oncology at Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland, discusses advancements in B-cell lymphoma therapy, focusing on novel treatments like immunotherapy and …

Source: Targeted Oncology - Label Pending
Published on Mar 21, 2025

Expert Discusses Navigating Anticoagulation in Older Adults | APhA 2025

Elizabeth Pogge, PharmD, professor in the College of Pharmacy at Midwestern University, focuses on risk assessment and anticoagulation management for older adults with atrial fibrillation, emphasizing the critical role of comprehensive risk scoring systems …

Source: Drug Topics - Neutral
Published on Mar 21, 2025

Nemtabrutinib Shows Promise in Relapsed/Refractory Follicular Lymphoma

Wojciech Jurczak, MD, PhD, head of the department of oncology at Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland, discusses nemtabrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor currently undergoing development for …

Source: Targeted Oncology - Label Pending
Published on Mar 20, 2025

Lee Evaluates Chronic GVHD Therapies for Depth and Durability of Response

Catherine J. Lee, MD, MS Associate Professor Clinical Research Division Fred Hutchinson Cancer Center Seattle, WA CASE SUMMARY A 48-year-old man underwent myeloablative conditioning and a matched unrelated donor hematopoietic cell transplant for acute …

Source: Targeted Oncology - Label Pending
Published on Mar 22, 2025

Life Line Screening Reviews: What You Need To Know?

AUSTIN, Texas, March 22, 2025 (GLOBE NEWSWIRE) -- You may have come across plenty of Life Line Screening reviews and articles. But not all of them come with the required information that you need. As such, we share with you this thoroughly researched Life …

Distribution channels: Banking, Finance & Investment Industry, Media, Advertising & PR ...
Published on Mar 20, 2025

Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community

Interactive Tool Harnesses Real-World Data to Visualize Burden of Disease in HCM and Advance Equitable Access to Care SOUTH SAN FRANCISCO, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the launch of …

Distribution channels:
Published on Mar 21, 2025

Mar 21 2025 This Week in Cardiology

Please note that the text below is not a full transcript and has not been copyedited. For more insight and commentary on these stories, subscribe to the This Week in Cardiology podcast, download the Medscape app or subscribe on Apple Podcasts, Spotify, or …

Source: Medscape - Neutral
Published on Mar 21, 2025

Heart Failure With Improved Ejection Fraction Is a Rising Focus in Cardiovascular Care

Heart failure (HF) is a complex medical condition that affects millions of patients globally. The disease state is characterized by the heart’s inability to adequately fill with or eject blood.1 Suboptimal ventricular function can be due to compromises in …

Source: Pharmacy Times - Neutral
Published on Mar 21, 2025

11 Analysts Have This To Say About AtriCure

Across the recent three months, 11 analysts have shared their insights on AtriCure ATRC, expressing a variety of opinions spanning from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past …

Source: myMotherLode - Label Pending
Published on Mar 21, 2025

Ask not what the NHS can do for you but what you can do for the NHS - Medical Matters with Derry GP Dr Tom Black

Watch more of our videos on ShotsTV.com and on Freeview 262 or Freely 565 Visit Shots! now I know that some people don’t want to hear that the NHS in Northern Ireland is in trouble with long waiting lists, not enough staff and a lack of funding but this …

Source: Derry Journal - Label Pending
Published on Mar 20, 2025

In CLL, Zanubrutinib Shows Better Safety Profile Than Ibrutinib

Zanubrutinib demonstrated a more favorable safety profile than ibrutinib for patients with chronic lymphocytic leukemia (CLL), with fewer serious adverse events (SAEs) and lower rates of treatment discontinuation due to toxicity, according to a study …

Source: The American Journal of Managed Care - Neutral
Published on Mar 20, 2025

Former NFL, UK football star Art Still working to shine spotlight on rare heart disease

LEXINGTON, Ky. (March 20, 2025) — Art Still is one of the best defensive ends in University of Kentucky football history, becoming the No. 2 overall pick in the 1978 NFL draft and playing in the NFL for 12 years — 10 of them with the Kansas City Chiefs. …

Source: UKNow - Kentucky - Label Pending

06 days 15:59:17

Featured Releases

Got News to Share? · Submit · See All

Published on March 25, 2025 - 11:30 GMT

Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other ...

Target Indications Also Include Peeling Skin Syndrome, SAM Syndrome, Palmoplantar Keratoderma and Severe Atopic Dermatitis Third Quoin Patent Application for Netherton Syndrome If Granted Company Would have Patent Protection for QRX003 for Netherton …

Distribution channels: Healthcare & Pharmaceuticals Industry, Law ...
Published on March 25, 2025 - 11:30 GMT

Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR

Preclinical and Phase 1 data suggest that ratutrelvir can be used without ritonavir and may reduce the likelihood of COVID rebound and the risk of long COVID due to a longer treatment regimen Preparations are underway for FDA interactions and initiation of …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on March 25, 2025 - 11:30 GMT

Relmada Therapeutics Licenses Phase 2 Bladder Cancer Candidate, NDV-01, from Trigone Pharma, Ltd.

NDV-01 is a novel, sustained-release, intravesical gemcitabine/docetaxel, ready-for-use product candidate for the treatment of non-muscle invasive bladder cancer (NMIBC, U.S. prevalence of ~600,000 patients, with ~62,000 newly diagnosed patients …

Distribution channels: Companies, Technology ...
Published on March 25, 2025 - 11:00 GMT

NMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel ...

Company presented clinical and preclinical data at the MDA Conference last week in Dallas, Texas Oral presentation included data from MuSK-MG rat model depicting increases in muscle function and improvements in the structural integrity of the neuromuscular …

Distribution channels: Media, Advertising & PR, Technology ...

Published on March 25, 2025 - 10:01 GMT

X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or 4Q 2025; top-line data anticipated in 2H 2026 4WARD trial protocol refined, increasing confidence in successful outcome 2024 …

Distribution channels:
Published on March 25, 2025 - 06:30 GMT

Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in Dermatology in Japan

- Alumis to receive $40 million in upfront and near-term co-development payments, with potential for approximately $140 million in additional milestone and field option payments, plus tiered royalties on future sales -Deal underscores the commercial …

Distribution channels: Technology ...
Published on March 25, 2025 - 06:00 GMT

NMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel ...

Company presented clinical and preclinical data at the MDA Conference last week in Dallas, Texas Oral presentation included data from MuSK-MG rat model depicting increases in muscle function and improvements in the structural integrity of the neuromuscular …

Distribution channels: Media, Advertising & PR, Technology ...
Published on March 25, 2025 - 03:13 GMT

Lawsuit Notice: Investors who hold Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares should contact the Shareholders ...

SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Investors who purchased shares of Regeneron Pharmaceuticals, …

Distribution channels: Consumer Goods, Media, Advertising & PR ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 796,914,693 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 03/19/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on March 25, 2025 - 11:55 GMT

Saving Lives: Angela Buckalew’s Mission to Improve AED Access, Training, and Compatibility

Angela Buckalew is breaking barriers in AED training and technology, ensuring more people are prepared to act in a cardiac emergency. CINCINNATI, OH, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Sudden cardiac arrest (SCA) is one of the …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on March 25, 2025 - 11:53 GMT

37% Drop in UK Work Visa Approvals: Get Sponsored Job Reveals Key Findings and Strategies for Job Seekers

UK work visa approvals dropped 37%. Get Sponsored Job (GSJ) advises targeting high-demand sectors, tailoring CVs, and networking to boost job search success. LONDON, UNITED KINGDOM, March 25, 2025 /⁨EINPresswire.com⁩/ -- The UK job market is …

Distribution channels: Business & Economy, Education ...
Published on March 25, 2025 - 11:30 GMT

Mobility City's Technician Network, the Largest HME Repair & Delivery Network, is Now an Accredited Exemplary Provider

Mobility City's franchise system, with the largest HME repair and delivery Technician Network in the US, is now a CMS approved Exemplary Provider BOCA RATON, FL, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Mobility City Holdings Inc, …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:30 GMT

Foreign Aid Bridge Fund Donations Surpass $1 Million

Emergency Funding Fuels Life-Saving Relief for Frontline Organizations Amid Rising Global Crises WASHINGTON, RI, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Foreign Aid Bridge Fund has surpassed $1 million in donations just over a …

Distribution channels: Emergency Services, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:00 GMT

CMTA’s $300K Investment in CRISPR for CMT2A

CMTA invests $300K in CRISPR gene editing for CMT2A at UCSF’s Gladstone Institutes, targeting MFN2 mutations to restore nerve function. GLENOLDEN, PA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth Association (CMTA …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:00 GMT

Dean Melissa Perry appointed to prestigious National Academies of Sciences, Engineering, and Medicine Committee

Perry appointed to NASEM Committee on Clinical Follow-Up and Care for Those Impacted by the JP-5 Releases at Red Hill. FAIRFAX, VA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- As a widely respected researcher and public health leader, …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:00 GMT

LarmorBio Announces Addition of Multiple New Board Members and Senior Executive Hires

Company Prepares to Scale Business with Proprietary Microscale Magnetic Resonance Technology BOSTON, MA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- LarmorBio, a Massachusetts Institute of Technology (MIT) start-up pioneering the use of …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:00 GMT

Enkrypt AI Launches New Multimodal AI Security Solution to Safeguard Text, Image, and Voice AI Systems

Innovative solution secures multimodal AI systems from emerging security, bias, and compliance risks BOSTON, MA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Enkrypt AI, a leader in AI security and compliance – is proud to announce the …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on March 25, 2025 - 10:45 GMT

Feroot Launches PaymentGuard AI: Automated PCI DSS 4 Compliance for Websites with E-commerce Payment Webpages.

PaymentGuard AI by Feroot Security: Automating PCI DSS 4 Compliance with Requirements 6.4.3 and 11.6.1 for SAQ D and SAQ A-EP E-Commerce Merchants. TORONTO, CANADA, March 25, 2025 /⁨EINPresswire.com⁩/ -- Feroot Security, a leader in cybersecurity …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:45 GMT

PUSH for Empowered Pregnancy Launches #MomentForStillness to Honor Babies Born Still and Demand Urgent Action

A Nationwide Call to Address Preventable Stillbirths Begins March 25th at Noon ET NEW YORK, NY, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- PUSH for Empowered Pregnancy is launching the #MomentForStillness campaign at noon ET on Tuesday, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:18 GMT

TravelingWiki Foundation Launches 'Card For a Cause' to Leverage Sports Cards for Free Non Visible Disability Resources

TravelingWiki Now Offers Free Resources in English, Spanish, French, German, Mandarin, Japanese, Hebrew, Arabic, Portuguese, Hindi, Twi, Vietnamese & Russian DES MOINES, IA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- TravelingWiki …

Distribution channels: Aviation & Aerospace Industry, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:00 GMT

PhenoBiome Welcomes New Leadership and Validates Breakthrough Microbiome Modulation

Brian Russon Named CEO, Kait Mikes Appointed COO as Company Advances Clinical Validation of Predictive Platform PALM SPRINGS, CA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- PhenoBiome, Inc., a pioneering leader in personalized …

Distribution channels: Business & Economy, Food & Beverage Industry ...
Published on March 25, 2025 - 09:45 GMT

Florida Mesothelioma Victims Center Has Endorsed the Gori Law Firm for a Former Power Plant Worker with Just Diagnosed ...

TAMPA , FL, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Florida Mesothelioma Victims Center says, "We have endorsed, and we highly recommend the Gori Law Firm for a former power plant worker with just diagnosed mesothelioma or …

Distribution channels: Automotive Industry, Building & Construction Industry ...
Published on March 25, 2025 - 09:43 GMT

OmnySense to Target Oncology Patients as Initial Focus for Its Transformative Personal Health-Assessment Solution

19m Americans have cancer. Unplanned acute visits drive nearly half the costs-creating a major unmet need and opportunity for innovative solutions TEL AVIV, ISRAEL, March 25, 2025 /⁨EINPresswire.com⁩/ -- OmnySense, an innovative digital health …

Distribution channels: Banking, Finance & Investment Industry, Emergency Services ...
Published on March 25, 2025 - 08:17 GMT

RSU Research Week Opening Session highlights the interaction between medicine, technology, and behavioural science

RSU Research Week 2025 opened on 24 March with an ambitious plenary session focusing on the role of research, technology, and the human factor in healthcare. RIGA, LATVIA, March 25, 2025 /⁨EINPresswire.com⁩/ -- RSU Research Week 2025 opened on 24 …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 08:09 GMT

Dan Pitulia Appointed as Group CEO of the Atlas Antibodies Group

The Board of Atlas Antibodies Group is pleased to announce the appointment of Dan Pitulia as the new Group Chief Executive Officer (CEO). STOCKHOLM, SWEDEN, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Board of Atlas Antibodies Group is pleased to announce …

Distribution channels: Business & Economy, Chemical Industry ...
Published on March 25, 2025 - 07:36 GMT

A' Wellness, Health Promotion, and Preventive Care Design Award Announces Comprehensive Prize Package for 2024

The prestigious A' Wellness, Health Promotion, and Preventive Care Design Award reveals an extensive array of benefits for 2024 competition laureates COMO, CO, ITALY, March 25, 2025 /⁨EINPresswire.com⁩/ -- The A' Wellness, Health Promotion …

Distribution channels: Business & Economy, Consumer Goods ...
Published on March 25, 2025 - 05:24 GMT

Unlocking the Potential of Tofacitinib: New Frontiers in Treating Skin Disorders

BRADENTON, FL, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Skin disease related to immune system problems can be a challenge to treat. A new drug, Tofacitinib has gained attention for its therapeutic effects in autoimmune and inflammatory …

Distribution channels: Beauty & Hair Care, Education ...
Published on March 25, 2025 - 05:08 GMT

Acclaim Autism Opens New Early Childhood ABA Therapy Center in Lancaster, PA

Acclaim Autism Opens New Early Childhood ABA Therapy Center in Lancaster, PA: Empowering young children with autism through individualized therapy. LANCASTER, PA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Acclaim Autism is thrilled to …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:30 GMT

Cognition Therapeutics to Report Biomarker Results from Phase 2 SHINE Study in Mild-to-Moderate Alzheimer’s Disease in ...

PURCHASE, N.Y., March 25, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, will be presenting biomarker results from the …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...